Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-9-17
pubmed:abstractText
We investigated the effects of NT-702, a selective phosphodiesterase (PDE) 3 inhibitor, on arterioles isolated from rabbit lumbar spinal cords. NT-702 caused a dose-dependent dilation of the isolated spinal arterioles. The disruption of endothelium produced a significant reduction of higher concentrations (10(-7) and 10(-6) M), but not lower concentrations (less than 10(-8) M), of NT-702-induced vasodilation. The NT-702-induced vasodilation of the arterioles with endothelium was not affected by pretreatment with an inhibitor of nitric oxide, cyclooxygenase, or cytochrome P-450 monooxygenase. In contrast, catalase reduced significantly the higher concentrations of NT-702-induced vasodilation only. Tetraethylammonium (TEA) completely reduced the lower concentrations of NT-702-induced vasodilation, but decreased only partially the higher concentrations of NT-702-induced vasodilation of the arterioles with endothelium. Hydrogen peroxide dilated significantly the isolated arterioles with endothelium, the response of which was reduced significantly by TEA. KT5720 (a selective protein kinase inhibitor) significantly decreased both the lower and higher concentrations of NT-702-induced vasodilation of the arterioles with endothelium. The findings suggest that NT-702 dose-dependently dilated the isolated spinal arterioles of rabbits via endothelium-dependent and endothelium-independent mechanisms. Protein kinase A (PKA)- and TEA-sensitive K(+) channels may be involved in the NT-702-induced vasodilation. Moreover, hydrogen peroxide may contribute in part to the endothelium-dependent higher concentrations of NT-702-induced vasodilation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/4-bromo-6-(3-(4-chlorophenyl)propoxy..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP-Dependent Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic Nucleotide..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Hydrogen Peroxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Donors, http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase 3 Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channels, http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandins, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Pyridazines, http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1880-6546
pubmed:author
pubmed:issnType
Print
pubmed:volume
58
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
229-37
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18558016-Animals, pubmed-meshheading:18558016-Arterioles, pubmed-meshheading:18558016-Cyclic AMP-Dependent Protein Kinases, pubmed-meshheading:18558016-Cyclic Nucleotide Phosphodiesterases, Type 3, pubmed-meshheading:18558016-Cyclooxygenase Inhibitors, pubmed-meshheading:18558016-Dose-Response Relationship, Drug, pubmed-meshheading:18558016-Endothelium, Vascular, pubmed-meshheading:18558016-Hydrogen Peroxide, pubmed-meshheading:18558016-Lumbosacral Region, pubmed-meshheading:18558016-Male, pubmed-meshheading:18558016-Nitric Oxide, pubmed-meshheading:18558016-Nitric Oxide Donors, pubmed-meshheading:18558016-Phosphodiesterase 3 Inhibitors, pubmed-meshheading:18558016-Phosphodiesterase Inhibitors, pubmed-meshheading:18558016-Potassium Channel Blockers, pubmed-meshheading:18558016-Potassium Channels, pubmed-meshheading:18558016-Prostaglandins, pubmed-meshheading:18558016-Protein Kinase Inhibitors, pubmed-meshheading:18558016-Pyridazines, pubmed-meshheading:18558016-Rabbits, pubmed-meshheading:18558016-Spinal Cord, pubmed-meshheading:18558016-Vasodilation, pubmed-meshheading:18558016-Vasodilator Agents
pubmed:year
2008
pubmed:articleTitle
NT-702, a selective phosphodiesterase 3 inhibitor, dilates rabbit spinal arterioles via endothelium-dependent and endothelium-independent mechanisms.
pubmed:affiliation
Department of Physiology, Shinshu University School of Medicine, Matsumoto, 390-8621 Japan.
pubmed:publicationType
Journal Article, In Vitro